La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The questionable use of unequal allocation in confirmatory trials

Identifieur interne : 000894 ( Main/Exploration ); précédent : 000893; suivant : 000895

The questionable use of unequal allocation in confirmatory trials

Auteurs : Spencer Phillips Hey ; Jonathan Kimmelman

Source :

RBID : PMC:3873626

Abstract

Randomization is the standard means for addressing known and unknown confounders within the patient population in clinical trials. Although random assignment to treatment arms on a 1:1 basis has long been the norm, many 2-armed confirmatory trials now use unequal allocation schemes where the number of patients receiving investigational interventions exceeds those in the comparator arm. In what follows, we offer 3 arguments for why investigators, institutional review boards, and data and safety monitoring boards should exercise caution when planning or reviewing 2-armed confirmatory trials involving unequal allocation ratios. We close by laying out some of the conditions where uneven allocation can be justified ethically.


Url:
DOI: 10.1212/01.wnl.0000438226.10353.1c
PubMed: 24306005
PubMed Central: 3873626


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The questionable use of unequal allocation in confirmatory trials</title>
<author>
<name sortKey="Hey, Spencer Phillips" sort="Hey, Spencer Phillips" uniqKey="Hey S" first="Spencer Phillips" last="Hey">Spencer Phillips Hey</name>
</author>
<author>
<name sortKey="Kimmelman, Jonathan" sort="Kimmelman, Jonathan" uniqKey="Kimmelman J" first="Jonathan" last="Kimmelman">Jonathan Kimmelman</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24306005</idno>
<idno type="pmc">3873626</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873626</idno>
<idno type="RBID">PMC:3873626</idno>
<idno type="doi">10.1212/01.wnl.0000438226.10353.1c</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">000615</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000615</idno>
<idno type="wicri:Area/Pmc/Curation">000615</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000615</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000393</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000393</idno>
<idno type="wicri:Area/Ncbi/Merge">001636</idno>
<idno type="wicri:Area/Ncbi/Curation">001636</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001636</idno>
<idno type="wicri:doubleKey">0028-3878:2014:Hey S:the:questionable:use</idno>
<idno type="wicri:Area/Main/Merge">000896</idno>
<idno type="wicri:Area/Main/Curation">000894</idno>
<idno type="wicri:Area/Main/Exploration">000894</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">The questionable use of unequal allocation in confirmatory trials</title>
<author>
<name sortKey="Hey, Spencer Phillips" sort="Hey, Spencer Phillips" uniqKey="Hey S" first="Spencer Phillips" last="Hey">Spencer Phillips Hey</name>
</author>
<author>
<name sortKey="Kimmelman, Jonathan" sort="Kimmelman, Jonathan" uniqKey="Kimmelman J" first="Jonathan" last="Kimmelman">Jonathan Kimmelman</name>
</author>
</analytic>
<series>
<title level="j">Neurology</title>
<idno type="ISSN">0028-3878</idno>
<idno type="eISSN">1526-632X</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>Randomization is the standard means for addressing known and unknown confounders within the patient population in clinical trials. Although random assignment to treatment arms on a 1:1 basis has long been the norm, many 2-armed confirmatory trials now use unequal allocation schemes where the number of patients receiving investigational interventions exceeds those in the comparator arm. In what follows, we offer 3 arguments for why investigators, institutional review boards, and data and safety monitoring boards should exercise caution when planning or reviewing 2-armed confirmatory trials involving unequal allocation ratios. We close by laying out some of the conditions where uneven allocation can be justified ethically.</p>
</div>
</front>
</TEI>
<affiliations>
<list></list>
<tree>
<noCountry>
<name sortKey="Hey, Spencer Phillips" sort="Hey, Spencer Phillips" uniqKey="Hey S" first="Spencer Phillips" last="Hey">Spencer Phillips Hey</name>
<name sortKey="Kimmelman, Jonathan" sort="Kimmelman, Jonathan" uniqKey="Kimmelman J" first="Jonathan" last="Kimmelman">Jonathan Kimmelman</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000894 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000894 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:3873626
   |texte=   The questionable use of unequal allocation in confirmatory trials
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24306005" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022